CA2240146C - Apparatus for lowering the intraocular pressure of an eye - Google Patents
Apparatus for lowering the intraocular pressure of an eye Download PDFInfo
- Publication number
- CA2240146C CA2240146C CA002240146A CA2240146A CA2240146C CA 2240146 C CA2240146 C CA 2240146C CA 002240146 A CA002240146 A CA 002240146A CA 2240146 A CA2240146 A CA 2240146A CA 2240146 C CA2240146 C CA 2240146C
- Authority
- CA
- Canada
- Prior art keywords
- implant
- eye
- anterior chamber
- foot portion
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000004410 intraocular pressure Effects 0.000 title claims abstract description 36
- 239000007943 implant Substances 0.000 claims abstract description 172
- 210000002159 anterior chamber Anatomy 0.000 claims abstract description 67
- 239000012528 membrane Substances 0.000 claims abstract description 32
- 238000001914 filtration Methods 0.000 claims abstract description 24
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 11
- 229920001519 homopolymer Polymers 0.000 claims abstract description 11
- 210000004087 cornea Anatomy 0.000 claims description 33
- 210000001742 aqueous humor Anatomy 0.000 claims description 19
- 238000003780 insertion Methods 0.000 claims description 13
- 230000037431 insertion Effects 0.000 claims description 13
- 206010016717 Fistula Diseases 0.000 claims description 12
- 230000003890 fistula Effects 0.000 claims description 12
- 238000002513 implantation Methods 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 8
- 238000009933 burial Methods 0.000 claims description 7
- 210000001585 trabecular meshwork Anatomy 0.000 claims description 6
- 229920002319 Poly(methyl acrylate) Polymers 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 4
- -1 polypropylene Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 239000003106 tissue adhesive Substances 0.000 claims description 4
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 3
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 32
- 210000001232 limbus corneae Anatomy 0.000 abstract description 9
- 210000001508 eye Anatomy 0.000 description 106
- 238000001356 surgical procedure Methods 0.000 description 31
- 208000010412 Glaucoma Diseases 0.000 description 23
- 210000004379 membrane Anatomy 0.000 description 22
- 210000000795 conjunctiva Anatomy 0.000 description 21
- 241000283973 Oryctolagus cuniculus Species 0.000 description 17
- 208000002352 blister Diseases 0.000 description 14
- 210000003786 sclera Anatomy 0.000 description 14
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000002980 postoperative effect Effects 0.000 description 5
- 201000004569 Blindness Diseases 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000004424 eye movement Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000001760 tenon capsule Anatomy 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010010716 Conjunctival erosion Diseases 0.000 description 2
- 206010052117 Corneal decompensation Diseases 0.000 description 2
- 208000005422 Foreign-Body reaction Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010049816 Muscle tightness Diseases 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010046851 Uveitis Diseases 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001886 ciliary effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 230000001497 fibrovascular Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- WLRMANUAADYWEA-NWASOUNVSA-N (S)-timolol maleate Chemical compound OC(=O)\C=C/C(O)=O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 WLRMANUAADYWEA-NWASOUNVSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 208000033310 Atrophy of globe Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000024304 Choroidal Effusions Diseases 0.000 description 1
- 206010008783 Choroidal detachment Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010061323 Optic neuropathy Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- 206010066902 Surgical failure Diseases 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 description 1
- 229960004324 betaxolol Drugs 0.000 description 1
- NWIUTZDMDHAVTP-UHFFFAOYSA-N betaxolol Chemical compound C1=CC(OCC(O)CNC(C)C)=CC=C1CCOCC1CC1 NWIUTZDMDHAVTP-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007978 cacodylate buffer Substances 0.000 description 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960003715 demecarium bromide Drugs 0.000 description 1
- YHKBUDZECQDYBR-UHFFFAOYSA-L demecarium bromide Chemical compound [Br-].[Br-].C=1C=CC([N+](C)(C)C)=CC=1OC(=O)N(C)CCCCCCCCCCN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 YHKBUDZECQDYBR-UHFFFAOYSA-L 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- OCUJLLGVOUDECM-UHFFFAOYSA-N dipivefrin Chemical compound CNCC(O)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1 OCUJLLGVOUDECM-UHFFFAOYSA-N 0.000 description 1
- 229960000966 dipivefrine Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229960002445 echothiophate iodide Drugs 0.000 description 1
- OVXQHPWHMXOFRD-UHFFFAOYSA-M ecothiopate iodide Chemical compound [I-].CCOP(=O)(OCC)SCC[N+](C)(C)C OVXQHPWHMXOFRD-UHFFFAOYSA-M 0.000 description 1
- 230000004406 elevated intraocular pressure Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007446 glucose tolerance test Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 238000012735 histological processing Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229960000831 levobunolol Drugs 0.000 description 1
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229960002704 metipranolol Drugs 0.000 description 1
- BQIPXWYNLPYNHW-UHFFFAOYSA-N metipranolol Chemical compound CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C BQIPXWYNLPYNHW-UHFFFAOYSA-N 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000004433 ocular motility Effects 0.000 description 1
- 208000020911 optic nerve disease Diseases 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003894 surgical glue Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960005221 timolol maleate Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000002691 topical anesthesia Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000003190 viscoelastic substance Substances 0.000 description 1
- 229940006076 viscoelastic substance Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Rehabilitation Tools (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Eye Examination Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/570,400 | 1995-12-11 | ||
| US08/570,400 US5704907A (en) | 1994-07-22 | 1995-12-11 | Method and apparatus for lowering the intraocular pressure of an eye |
| PCT/US1996/007724 WO1997021406A1 (en) | 1995-12-11 | 1996-05-24 | Apparatus for lowering the intraocular pressure of an eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2240146A1 CA2240146A1 (en) | 1997-06-19 |
| CA2240146C true CA2240146C (en) | 2010-03-09 |
Family
ID=24279508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002240146A Expired - Fee Related CA2240146C (en) | 1995-12-11 | 1996-05-24 | Apparatus for lowering the intraocular pressure of an eye |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5704907A (enExample) |
| EP (1) | EP0866680B1 (enExample) |
| JP (1) | JP4082729B2 (enExample) |
| KR (1) | KR100478355B1 (enExample) |
| AT (1) | ATE290838T1 (enExample) |
| AU (1) | AU730161B2 (enExample) |
| CA (1) | CA2240146C (enExample) |
| DE (1) | DE69634491T2 (enExample) |
| ES (1) | ES2239331T3 (enExample) |
| WO (1) | WO1997021406A1 (enExample) |
Families Citing this family (134)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6102045A (en) * | 1994-07-22 | 2000-08-15 | Premier Laser Systems, Inc. | Method and apparatus for lowering the intraocular pressure of an eye |
| US5968058A (en) * | 1996-03-27 | 1999-10-19 | Optonol Ltd. | Device for and method of implanting an intraocular implant |
| US6050970A (en) * | 1997-05-08 | 2000-04-18 | Pharmacia & Upjohn Company | Method and apparatus for inserting a glaucoma implant in an anterior and posterior segment of the eye |
| US8313454B2 (en) | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
| US6203513B1 (en) | 1997-11-20 | 2001-03-20 | Optonol Ltd. | Flow regulating implant, method of manufacture, and delivery device |
| TR200103098T2 (tr) * | 1999-04-26 | 2002-04-22 | Gmp Vision Solutions, Inc. | Glokom tedavisi için döndürme aleti ve yöntemi. |
| US20050119601A9 (en) * | 1999-04-26 | 2005-06-02 | Lynch Mary G. | Shunt device and method for treating glaucoma |
| US6558342B1 (en) | 1999-06-02 | 2003-05-06 | Optonol Ltd. | Flow control device, introducer and method of implanting |
| US20020143284A1 (en) * | 2001-04-03 | 2002-10-03 | Hosheng Tu | Drug-releasing trabecular implant for glaucoma treatment |
| US6638239B1 (en) * | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
| US20040111050A1 (en) * | 2000-04-14 | 2004-06-10 | Gregory Smedley | Implantable ocular pump to reduce intraocular pressure |
| US20050049578A1 (en) * | 2000-04-14 | 2005-03-03 | Hosheng Tu | Implantable ocular pump to reduce intraocular pressure |
| US7708711B2 (en) * | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
| US6533768B1 (en) | 2000-04-14 | 2003-03-18 | The Regents Of The University Of California | Device for glaucoma treatment and methods thereof |
| US20050277864A1 (en) * | 2000-04-14 | 2005-12-15 | David Haffner | Injectable gel implant for glaucoma treatment |
| US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
| US7635388B1 (en) * | 2000-05-04 | 2009-12-22 | Tyler Thomas D | Device and method for incremental correction of sight disorders and occular diseases |
| US9603741B2 (en) | 2000-05-19 | 2017-03-28 | Michael S. Berlin | Delivery system and method of use for the eye |
| WO2001089437A2 (en) * | 2000-05-19 | 2001-11-29 | Berlin Michael S | Laser delivery system and method of use for the eye |
| US8679089B2 (en) | 2001-05-21 | 2014-03-25 | Michael S. Berlin | Glaucoma surgery methods and systems |
| US6962573B1 (en) | 2000-10-18 | 2005-11-08 | Wilcox Michael J | C-shaped cross section tubular ophthalmic implant for reduction of intraocular pressure in glaucomatous eyes and method of use |
| US6595945B2 (en) | 2001-01-09 | 2003-07-22 | J. David Brown | Glaucoma treatment device and method |
| US6881198B2 (en) * | 2001-01-09 | 2005-04-19 | J. David Brown | Glaucoma treatment device and method |
| US7488303B1 (en) | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
| US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
| WO2002080811A2 (en) | 2001-04-07 | 2002-10-17 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| US6666841B2 (en) | 2001-05-02 | 2003-12-23 | Glaukos Corporation | Bifurcatable trabecular shunt for glaucoma treatment |
| US6981958B1 (en) * | 2001-05-02 | 2006-01-03 | Glaukos Corporation | Implant with pressure sensor for glaucoma treatment |
| US7678065B2 (en) * | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
| AU2002305400A1 (en) * | 2001-05-03 | 2002-11-18 | Glaukos Corporation | Medical device and methods of use for glaucoma treatment |
| US7331984B2 (en) * | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
| CA2462768A1 (en) * | 2001-10-02 | 2003-07-10 | Trustees Of Tufts College | Self-assembling polymers, and materials fabricated therefrom |
| US20030097151A1 (en) * | 2001-10-25 | 2003-05-22 | Smedley Gregory T. | Apparatus and mitochondrial treatment for glaucoma |
| US7163543B2 (en) * | 2001-11-08 | 2007-01-16 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
| US7186232B1 (en) | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
| US7951155B2 (en) | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
| US9301875B2 (en) * | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
| US20040147870A1 (en) * | 2002-04-08 | 2004-07-29 | Burns Thomas W. | Glaucoma treatment kit |
| US20040024345A1 (en) * | 2002-04-19 | 2004-02-05 | Morteza Gharib | Glaucoma implant with valveless flow bias |
| CA2493010C (en) * | 2002-07-19 | 2011-09-13 | Yale University | Uveoscleral drainage device |
| US7037335B2 (en) | 2002-11-19 | 2006-05-02 | Eagle Vision, Inc. | Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma |
| US7160264B2 (en) | 2002-12-19 | 2007-01-09 | Medtronic-Xomed, Inc. | Article and method for ocular aqueous drainage |
| US20040225250A1 (en) | 2003-05-05 | 2004-11-11 | Michael Yablonski | Internal shunt and method for treating glaucoma |
| WO2004110391A2 (en) * | 2003-06-16 | 2004-12-23 | Solx, Inc. | Shunt for the treatment of glaucoma |
| US7291125B2 (en) * | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
| WO2005072294A2 (en) * | 2004-01-22 | 2005-08-11 | Solx, Inc. | Glaucoma treatment method |
| US20050250788A1 (en) * | 2004-01-30 | 2005-11-10 | Hosheng Tu | Aqueous outflow enhancement with vasodilated aqueous cavity |
| US7862531B2 (en) * | 2004-06-25 | 2011-01-04 | Optonol Ltd. | Flow regulating implants |
| US20070156079A1 (en) * | 2005-09-16 | 2007-07-05 | Bg Implant, Inc. | Glaucoma Treatment Devices and Methods |
| PT2526910E (pt) | 2006-01-17 | 2015-11-18 | Transcend Medical Inc | Dispositivo para tratamento de glaucoma |
| EP3338743A1 (en) | 2006-01-17 | 2018-06-27 | Novartis Ag | Drug delivery treatment device |
| US20070293807A1 (en) * | 2006-05-01 | 2007-12-20 | Lynch Mary G | Dual drainage pathway shunt device and method for treating glaucoma |
| US9095411B2 (en) | 2010-11-15 | 2015-08-04 | Aquesys, Inc. | Devices for deploying intraocular shunts |
| US8721702B2 (en) | 2010-11-15 | 2014-05-13 | Aquesys, Inc. | Intraocular shunt deployment devices |
| US8852256B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for intraocular shunt placement |
| US8828070B2 (en) | 2010-11-15 | 2014-09-09 | Aquesys, Inc. | Devices for deploying intraocular shunts |
| US8663303B2 (en) | 2010-11-15 | 2014-03-04 | Aquesys, Inc. | Methods for deploying an intraocular shunt from a deployment device and into an eye |
| US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
| US10085884B2 (en) | 2006-06-30 | 2018-10-02 | Aquesys, Inc. | Intraocular devices |
| US8308701B2 (en) | 2010-11-15 | 2012-11-13 | Aquesys, Inc. | Methods for deploying intraocular shunts |
| US20080108933A1 (en) * | 2006-06-30 | 2008-05-08 | Dao-Yi Yu | Methods, Systems and Apparatus for Relieving Pressure in an Organ |
| US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
| US20120123316A1 (en) | 2010-11-15 | 2012-05-17 | Aquesys, Inc. | Intraocular shunts for placement in the intra-tenon's space |
| US8974511B2 (en) | 2010-11-15 | 2015-03-10 | Aquesys, Inc. | Methods for treating closed angle glaucoma |
| US8801766B2 (en) | 2010-11-15 | 2014-08-12 | Aquesys, Inc. | Devices for deploying intraocular shunts |
| JP5748407B2 (ja) | 2006-11-10 | 2015-07-15 | グローコス コーポレーション | ブドウ膜強膜シャント |
| JP4957258B2 (ja) * | 2007-01-15 | 2012-06-20 | 富士通株式会社 | 歩数計数装置および歩数計数方法 |
| US20080277332A1 (en) * | 2007-05-11 | 2008-11-13 | Becton, Dickinson And Company | Micromachined membrane filter device for a glaucoma implant and method for making the same |
| WO2008154502A1 (en) * | 2007-06-07 | 2008-12-18 | Yale University | Uveoscleral drainage device |
| WO2009012406A1 (en) | 2007-07-17 | 2009-01-22 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities reference to priority document |
| US8968396B2 (en) | 2007-07-23 | 2015-03-03 | Powervision, Inc. | Intraocular lens delivery systems and methods of use |
| EP2198816A4 (en) * | 2007-09-07 | 2010-11-10 | Yugen Kaisha Conan | DRAINAGE DEVICE FOR OPHTHALMIC SURGERY |
| US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
| US8109896B2 (en) | 2008-02-11 | 2012-02-07 | Optonol Ltd. | Devices and methods for opening fluid passageways |
| CA2717441A1 (en) | 2008-03-05 | 2009-09-11 | Ivantis, Inc. | Methods and apparatus for treating glaucoma |
| US8617139B2 (en) * | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
| US20100106255A1 (en) * | 2008-10-24 | 2010-04-29 | Dubin Marc G | Self-expanding frontal sinus stent and insertion tool |
| US8353856B2 (en) | 2008-11-05 | 2013-01-15 | Abbott Medical Optics Inc. | Glaucoma drainage shunts and methods of use |
| ES2817775T3 (es) * | 2009-01-28 | 2021-04-08 | Alcon Inc | Implante ocular con calidades de rigidez |
| US8702639B2 (en) * | 2009-03-26 | 2014-04-22 | Abbott Medical Optics Inc. | Glaucoma shunts with flow management and improved surgical performance |
| CA2764862C (en) * | 2009-06-25 | 2017-08-29 | Optonol Ltd. | Fiber matrix for maintaining space in soft tissues |
| CA2766192C (en) | 2009-07-09 | 2017-10-24 | Ivantis, Inc. | Ocular implants for residing partially in schlemm's canal |
| US9693899B2 (en) | 2009-07-09 | 2017-07-04 | Ivantis, Inc. | Single operator device for delivering an ocular implant |
| US20110105990A1 (en) * | 2009-11-04 | 2011-05-05 | Silvestrini Thomas A | Zonal drug delivery device and method |
| US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
| US8585629B2 (en) | 2010-11-15 | 2013-11-19 | Aquesys, Inc. | Systems for deploying intraocular shunts |
| US10842671B2 (en) | 2010-11-15 | 2020-11-24 | Aquesys, Inc. | Intraocular shunt placement in the suprachoroidal space |
| EP2517619B1 (en) | 2011-04-27 | 2013-05-22 | Istar Medical | Improvements in or relating to glaucoma management and treatment |
| US20120283557A1 (en) | 2011-05-05 | 2012-11-08 | Berlin Michael S | Methods and Apparatuses for the Treatment of Glaucoma using visible and infrared ultrashort laser pulses |
| US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
| US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
| US8852136B2 (en) | 2011-12-08 | 2014-10-07 | Aquesys, Inc. | Methods for placing a shunt into the intra-scleral space |
| US9808373B2 (en) | 2013-06-28 | 2017-11-07 | Aquesys, Inc. | Intraocular shunt implantation |
| US8765210B2 (en) | 2011-12-08 | 2014-07-01 | Aquesys, Inc. | Systems and methods for making gelatin shunts |
| US9610195B2 (en) | 2013-02-27 | 2017-04-04 | Aquesys, Inc. | Intraocular shunt implantation methods and devices |
| US10080682B2 (en) | 2011-12-08 | 2018-09-25 | Aquesys, Inc. | Intrascleral shunt placement |
| US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
| US9173775B2 (en) | 2012-03-26 | 2015-11-03 | Glaukos Corporation | System for delivering multiple ocular implants |
| US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
| US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
| US9241832B2 (en) | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
| RU2650203C2 (ru) | 2012-09-17 | 2018-04-11 | Новартис Аг | Устройства расширяющихся офтальмологических имплантатов |
| US9763829B2 (en) | 2012-11-14 | 2017-09-19 | Novartis Ag | Flow promoting ocular implant |
| US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
| US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
| US10159600B2 (en) | 2013-02-19 | 2018-12-25 | Aquesys, Inc. | Adjustable intraocular flow regulation |
| US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
| US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
| US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| JP6717740B2 (ja) | 2013-03-15 | 2020-07-01 | パワーヴィジョン・インコーポレーテッド | 眼内レンズの収容および載置装置ならびにその使用方法 |
| US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
| MX2016006297A (es) | 2013-11-14 | 2016-07-26 | Aquesys Inc | Insertador de derivacion intraocular. |
| EP3677229A1 (en) | 2014-05-29 | 2020-07-08 | Glaukos Corporation | Implants with controlled drug delivery features |
| PE20151266A1 (es) * | 2014-07-01 | 2015-09-10 | Velasquez Mario Eduardo Miranda | Dispositivo de drenaje para el control de la presion intraocular en glaucoma |
| US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
| JP7030516B2 (ja) | 2014-12-31 | 2022-03-07 | マイクロオプティクス インコーポレイテッド | 緑内障治療装置および方法 |
| FR3034308B1 (fr) * | 2015-03-31 | 2022-01-21 | Philippe Sourdille | Implant ophtalmologique d'interposition |
| CA2987953C (en) | 2015-06-03 | 2023-04-04 | Aquesys, Inc. | Ab externo intraocular shunt placement |
| US10842916B2 (en) | 2015-06-24 | 2020-11-24 | Healionics Corporation | Injectable porous device for treatment of dry and wet age-related macular degeneration or diabetic retinopathy |
| ES2962607T3 (es) | 2015-08-14 | 2024-03-20 | Alcon Inc | Implante ocular con sensor de presión |
| WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
| JP6892693B2 (ja) | 2015-09-30 | 2021-06-23 | マイクロオプティクス インコーポレイテッド | ドライアイ治療装置および方法 |
| US11938058B2 (en) | 2015-12-15 | 2024-03-26 | Alcon Inc. | Ocular implant and delivery system |
| CA3025526A1 (en) | 2016-06-02 | 2017-12-07 | Aquesys, Inc. | Intraocular drug delivery |
| GB201705177D0 (en) * | 2017-03-31 | 2017-05-17 | Sharma Anant | Device to aid movement of substance from the eye |
| US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
| US11246753B2 (en) | 2017-11-08 | 2022-02-15 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
| CA3091154C (en) | 2018-02-22 | 2023-10-03 | Ivantis, Inc. | Ocular implant and delivery system |
| US11135089B2 (en) | 2018-03-09 | 2021-10-05 | Aquesys, Inc. | Intraocular shunt inserter |
| US10952898B2 (en) | 2018-03-09 | 2021-03-23 | Aquesys, Inc. | Intraocular shunt inserter |
| US11672701B2 (en) * | 2018-10-25 | 2023-06-13 | Amo Groningen B.V. | Bleb control glaucoma shunts |
| EP3973933A1 (en) | 2019-06-26 | 2022-03-30 | Imvalv S.A. | Glaucoma drain implant system with pressure sensor and valve, and external reading unit |
| KR20230130622A (ko) | 2021-01-11 | 2023-09-12 | 알콘 인코포레이티드 | 점탄성 전달을 위한 시스템 및 방법 |
| WO2024044300A1 (en) * | 2022-08-26 | 2024-02-29 | W. L. Gore & Associates, Inc. | Biological fluid drainage devices and methods |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3915172A (en) * | 1970-05-27 | 1975-10-28 | Ceskoslovenska Akademie Ved | Capillary drain for glaucoma |
| US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
| US4060081A (en) * | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
| US4186184A (en) * | 1977-12-27 | 1980-01-29 | Alza Corporation | Selective administration of drug with ocular therapeutic system |
| US4457757A (en) * | 1981-07-20 | 1984-07-03 | Molteno Anthony C B | Device for draining aqueous humour |
| US4501263A (en) * | 1982-03-31 | 1985-02-26 | Harbuck Stanley C | Method for reducing hypertension of a liver |
| US4554918A (en) * | 1982-07-28 | 1985-11-26 | White Thomas C | Ocular pressure relief device |
| US4521210A (en) * | 1982-12-27 | 1985-06-04 | Wong Vernon G | Eye implant for relieving glaucoma, and device and method for use therewith |
| US4787885A (en) * | 1984-04-06 | 1988-11-29 | Binder Perry S | Hydrogel seton |
| US4729761A (en) * | 1985-11-27 | 1988-03-08 | White Thomas C | Tissue-implantable, fluid-dissipating device |
| NZ215409A (en) * | 1986-03-07 | 1989-02-24 | Anthony Christopher Be Molteno | Implant for drainage of aqueous humour in glaucoma |
| US4826478A (en) * | 1986-06-23 | 1989-05-02 | Stanley Schocket | Anterior chamber tube shunt to an encircling band, and related surgical procedure |
| US4722724A (en) * | 1986-06-23 | 1988-02-02 | Stanley Schocket | Anterior chamber tube shunt to an encircling band, and related surgical procedure |
| US4886488A (en) * | 1987-08-06 | 1989-12-12 | White Thomas C | Glaucoma drainage the lacrimal system and method |
| US4853375A (en) * | 1987-09-16 | 1989-08-01 | The Trustees Of The University Of Pennsylvania | Method of lowering intraocular (eye) pressure |
| US4936825A (en) * | 1988-04-11 | 1990-06-26 | Ungerleider Bruce A | Method for reducing intraocular pressure caused by glaucoma |
| US5360611A (en) * | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
| US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
| US4946436A (en) * | 1989-11-17 | 1990-08-07 | Smith Stewart G | Pressure-relieving device and process for implanting |
| US4968296A (en) * | 1989-12-20 | 1990-11-06 | Robert Ritch | Transscleral drainage implant device for the treatment of glaucoma |
| US5073163A (en) * | 1990-01-29 | 1991-12-17 | Lippman Myron E | Apparatus for treating glaucoma |
| US5127901A (en) * | 1990-05-18 | 1992-07-07 | Odrich Ronald B | Implant with subconjunctival arch |
| US5041081A (en) * | 1990-05-18 | 1991-08-20 | Odrich Ronald B | Ocular implant for controlling glaucoma |
| US5178604A (en) * | 1990-05-31 | 1993-01-12 | Iovision, Inc. | Glaucoma implant |
| US5397300A (en) * | 1990-05-31 | 1995-03-14 | Iovision, Inc. | Glaucoma implant |
| WO1992000112A1 (en) * | 1990-06-25 | 1992-01-09 | Ungerleider Bruce A | Apparatus for reducing intraocular pressure |
| US5171213A (en) * | 1991-08-14 | 1992-12-15 | Price Jr Francis W | Technique for fistulization of the eye and an eye filtration prosthesis useful therefor |
| WO1993012735A1 (en) * | 1992-01-02 | 1993-07-08 | Chiron Intraoptics, Inc. | Corneal ring inlay and methods of use |
| AU3469893A (en) * | 1992-01-15 | 1993-08-03 | Allergan, Inc. | Hydrogel compositions and structures made from same |
| US5370607A (en) * | 1992-10-28 | 1994-12-06 | Annuit Coeptis, Inc. | Glaucoma implant device and method for implanting same |
| US5338291A (en) * | 1993-02-03 | 1994-08-16 | Pudenz-Schulte Medical Research Corporation | Glaucoma shunt and method for draining aqueous humor |
| US5395356A (en) * | 1993-06-04 | 1995-03-07 | Summit Technology, Inc. | Correction of presbyopia by photorefractive keratectomy |
| US5520631A (en) * | 1994-07-22 | 1996-05-28 | Wound Healing Of Oklahoma | Method and apparatus for lowering the intraocular pressure of an eye |
-
1995
- 1995-12-11 US US08/570,400 patent/US5704907A/en not_active Expired - Lifetime
-
1996
- 1996-05-24 CA CA002240146A patent/CA2240146C/en not_active Expired - Fee Related
- 1996-05-24 DE DE69634491T patent/DE69634491T2/de not_active Expired - Fee Related
- 1996-05-24 AU AU58782/96A patent/AU730161B2/en not_active Ceased
- 1996-05-24 ES ES96920501T patent/ES2239331T3/es not_active Expired - Lifetime
- 1996-05-24 JP JP52200997A patent/JP4082729B2/ja not_active Expired - Fee Related
- 1996-05-24 KR KR10-1998-0704394A patent/KR100478355B1/ko not_active Expired - Fee Related
- 1996-05-24 EP EP96920501A patent/EP0866680B1/en not_active Expired - Lifetime
- 1996-05-24 WO PCT/US1996/007724 patent/WO1997021406A1/en not_active Ceased
- 1996-05-24 AT AT96920501T patent/ATE290838T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69634491D1 (de) | 2005-04-21 |
| ES2239331T3 (es) | 2005-09-16 |
| WO1997021406A1 (en) | 1997-06-19 |
| KR19990072086A (ko) | 1999-09-27 |
| AU5878296A (en) | 1997-07-03 |
| US5704907A (en) | 1998-01-06 |
| EP0866680A1 (en) | 1998-09-30 |
| EP0866680B1 (en) | 2005-03-16 |
| CA2240146A1 (en) | 1997-06-19 |
| KR100478355B1 (ko) | 2005-06-16 |
| ATE290838T1 (de) | 2005-04-15 |
| DE69634491T2 (de) | 2006-04-13 |
| JP4082729B2 (ja) | 2008-04-30 |
| AU730161B2 (en) | 2001-03-01 |
| JP2001517097A (ja) | 2001-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2240146C (en) | Apparatus for lowering the intraocular pressure of an eye | |
| US6102045A (en) | Method and apparatus for lowering the intraocular pressure of an eye | |
| US5520631A (en) | Method and apparatus for lowering the intraocular pressure of an eye | |
| McDonnell et al. | Molteno implant for control of glaucoma in eyes after penetrating keratoplasty | |
| US9844462B2 (en) | Internal shunt and method for treating glaucoma | |
| SHAFFER et al. | Concerning cyclodialysis and hypotony | |
| AU768116B2 (en) | Sutureless implantable device and method for treatment of glaucoma | |
| Freedman et al. | Molteno implants as a treatment for refractory glaucoma in black patients | |
| RU2143250C1 (ru) | Способ лечения больных с сочетанием катаракты и глаукомы | |
| Mamalis et al. | Combined phacoemulsification, intraocular lens implantation, and trabeculectomy | |
| Feldman et al. | Valve membrane adhesion as a cause of Ahmed glaucoma valve failure | |
| SCHEIE | Goniopuncture—A new filtering operation for glaucoma: Preliminary report | |
| Epstein | Cyclodialysis | |
| Sidoti et al. | Epithelial ingrowth and glaucoma drainage implants | |
| Fish et al. | Molteno implantation for secondary glaucomas associated with advanced epithelial ingrowth | |
| Anwar et al. | Lens capsule inclusion in trabeculectomy with cataract extraction | |
| RU2297815C1 (ru) | Способ хирургического лечения рефракторных глауком | |
| RU2300352C1 (ru) | Способ одномоментного хирургического лечения катаракты, сочетанной с открыто- или узкоугольной глаукомой, с использованием единого операционного доступа и имплантацией интраокулярной линзы | |
| RU2763875C1 (ru) | Способ хирургического лечения глаукомы с помощью микроинвазивной трабекулэктомии с фиксированным ириденклейзисом и аутоклапанным дренированием | |
| RU2140777C1 (ru) | Способ хирургического лечения глаукомы | |
| SU1739992A1 (ru) | Способ лечени вторичной глаукомы на афакичных и артифакичных глазах, сопровождающейс поражением роговицы | |
| Coleman et al. | Aqueous shunts | |
| DeVoe | A gonioscopic study of fistulizing operations | |
| Cohn | The history of filtering surgery | |
| DEEP | Dida Kazakova¹ 23*, Andre Mermoud and Gunther Krieglstein3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20130524 |